The Israeli businessman's long term aim is to build Phcann in the medical cannabis market in Europe including the UK, as well as in Australia. Israeli cannabis entrepreneur Yuval Soiref is teaming with legendary boxer Mike Tyson to exclusively market Tyson 2.0 medical cannabis in Germany.
Since April 1 2024, cannabis has been taken off the list of prohibited drugs in Germany, and its use has become legally permitted. Thus Germany has joined some of the states in the US and become the biggest European country to implement legalization of the cannabis market. Soiref's company Phcann specializes in the marketing and distribution of medical cannabis brands of former and present sports stars.
Tyson 2.0 products are already available in Germany, which is now hosting the Euro 2024 tournament attended by millions of soccer fans from around the world, some of them cannabis users. The exclusive marketing agreement also includes the UK, meaning that Soiref will produce and market Tyson 2.
0 products throughout the UK, subject to the British regulatory conditions. Yuval Soiref (33), is the cofounder of the Phcann International medical cannabis solutions products group and he began his career in the cannabis market ten years ago, when together with his father Vadim Soiref, he acquired a major holding in the Canadian cannabis company MedReleaf. The two men were in fact the first investors in the Canadian company, which was sold in 2018 to the Canadian company Aurora for US$2.
5 billion, yiel.